Research | Clinical Trials | Clinical Trial Details Page

Pharmacogenetics of Cannabinoid Response

Conditions

COMT Gene Polymorphism

Trial Phase

Phase 1

Trial Purpose and Description

Trial Purpose

This study attempts to examine genetic influences on the effects of tetrahydrocannabinol (Δ9-THC), the active ingredient of marijuana, cannabis, "ganja", or "pot".


Participation Guidelines

Age:
18 Years - 55 Years
Gender:
Both

Eligibility Criteria


Inclusion Criteria:

- 18 and 55 years (extremes included) on the day of the first dosing.

Exclusion Criteria:

- Cannabis na7ve individuals.
Sponsor:
National Institute on Drug Abuse (NIDA)
Yale University
Dates:
July 2007
Last Updated:
October 25, 2012
Study HIC#:
0706002754

Clinicaltrials.gov ID: NCT00678730